EPIC BIO Trademark

Trademark Overview


On Wednesday, February 23, 2022, a trademark application was filed for EPIC BIO with the United States Patent and Trademark Office. The USPTO has given the EPIC BIO trademark a serial number of 97280933. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, December 5, 2023. This trademark is owned by Epicrispr Biotechnologies, Inc.. The EPIC BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto
epic bio

General Information


Serial Number97280933
Word MarkEPIC BIO
Filing DateWednesday, February 23, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, December 5, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the terms epic and bio in lower case characters. The "dot" on the letter "i" in the term epic is below that letter rather than above; both that "dot" and the one on the letter "i" in the term bio are depicted as arrows. The two terms are separated by curved diagonal chain of dots which are faint at the top of the chain and intensify in appearance along the length of the chain.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development services, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto; Medical research services, namely, development of genetic medicine therapies, all of the foregoing in the fields of gene regulation and epigenetics and the use of crispr technology in relation thereto

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 1, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpicrispr Biotechnologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Saturday, February 26, 2022NEW APPLICATION ENTERED
Tuesday, March 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 2, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 7, 2022ASSIGNED TO EXAMINER
Thursday, December 15, 2022NON-FINAL ACTION WRITTEN
Thursday, December 15, 2022NON-FINAL ACTION E-MAILED
Thursday, December 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 15, 2023FINAL REFUSAL WRITTEN
Wednesday, March 15, 2023FINAL REFUSAL E-MAILED
Wednesday, March 15, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 12, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, June 12, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, December 5, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 5, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, December 5, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND